AMI Research Initiates Analyst Coverage On Advanced Medical Isotope Corp.; SPECULATIVE BUY
NEW YORK, June 06, 2013 -- AMI Research, a leading provider of equity research reports and a subsidiary of Hawk Associates Inc., announced today that it has initiated equity research coverage on Advanced Medical Isotope Corp (OTC: ADMD).
AMI president Peter J. D’Agostino said, “ADMD is poised for substantial growth with the company’s groundbreaking brachytherapy technology nearing commercialization. We also think that ADMD’s expected launch of an isotope production facility in Los Angeles is a win-win for hospitals, researchers, and patients and offers the company access to a new, larger medical market. As a result of these catalysts, we expect significant revenue increases in 2014 and 2015.”
AMI Research provides an institutional-quality, equity research initiation report detailing ADMD’s key statistics, management, growth catalysts, financial outlook, price target, and valuation. The complete eight-page report is available to download for free at the AMI Research website, http://www.amistockreports.com/ADMD_Initiation.pdf
About Advanced Medical Isotope Corp.
Headquartered in Kennewick, WA, Advanced Medical Isotope Corporation engages in the production and distribution of medical isotopes and medical isotope technologies. ADMD’s medical isotopes are used in molecular imaging, therapy, and nuclear medicine to diagnose, manage, and treat diseases. The company offers a line of stable isotopes, as well as radiopharmaceuticals for use in connection with positron emission tomography (PET). Also, ADMD is in the process of developing next-generation brachytherapy. Further, it provides consulting services. The company’s customers include a range of hospitals, universities, research centers, and national laboratories, as well as academic and government institutions in the US and internationally. For additional information about ADMD, visit http://www.isotopeworld.com.
About AMI Research
AMI Research provides equity research coverage for promising companies that do not have traditional Wall Street analyst coverage. Coverage by AMI ensures an objective explanation of all facets of a business and increased exposure to numerous institutional and retail investors seeking reputable investment ideas. AMI combines in-depth, insightful research and customized graphics into detailed analyst reports to create an investment thesis with a four tier rating system and 12-month price target. These reports detail the company’s industry, strategic position, core business model, financial history, future growth catalysts and projected financials. Please visit http://www.amistockreports.com. For more information, contact Peter J. D’Agostino, president at 212.541.2465, email to: email@example.com .
- Contact Information
- Peter J D’Agostino
- AMI Research
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.